HIV Rapid Test Kit , Home HIV Self Test Kit
One Step Anti-HIV1+2 in whole Blood Test is a rapid direct binding screening test for the presence of antibodies to HIV 1 and HIV 2. The test is based on the principle of double antigen sandwich immunoassay for the qualitative detection of Anti-HIV in human whole blood. Purified recombinant antigens are employed to identify Anti-HIV specifically. This one-step test is very sensitive and only takes about 15 minutes. Test results are read visually without any instrumentation.
Retail price
$ 0
Market price
$ 0
Category：
重量
0
Stock:
0
隐藏域元素占位
- Product Detail
- Accessories
- Technical Specification
- Product Tags
-
Product Specifications
Product Name
HIV Rapid Test Kit Sample type
Serum, Plasma or Whole Blood Detection type
Qualitative Method
Colloidal Gold Rapid Test Usage/Application
Laboratory / Hospital / Pathology /Home Self Test Function
Diagnose Certificate
ISO9001/ ISO13485/ CE by TUV/ MHRA/ WHO Format
Strip, Cassette, Midstream Sensitivity
100% Specificity
100% Total Accuracy
100% Reading time
5-20 minutes Packaging Details
Pouch+Box+Carton packaging Intended Application
Newscen HIV (1+2) Antibody Rapid Test is a single-use, rapid immunoassay for the qualitative detection of antibodies to Human Immunodeficiency Virus type 1 and 2 (HIV-1/ 2) in human serum, plasma or whole blood collected from vein or fingertip. It is intended for use in medical institutions by trained staff.
Working Principles
HIV-1 (gp41 and gp120) and HIV-2 (gp36) specific recombinant antigens are separately precoated onto the membrane in zone 1 and 2 as the capture reagent on the test zone. During the test, the specimen is allowed to react with the colloidal gold particles, which have been conjugated with HIV-1 and HIV-2 specific recombinant antigens. Antibodies to HIV-1 and/ or HIV-2, if present, will specifically bind to the colloidal gold-antigen complex.
When the colloidal gold-antigen-antibody complexes move to the test zone, they will specifically bind to the pre-coated antigens. At the same time, a red-colored line will develop in zone 1 and/ or 2 on the membrane. The absence of these red-colored lines in the test zone (1 and 2) suggests a negative result. To serve as a procedural control, a red-colored line in the control zone will always appear regardless of the presence of antibodies to HIV-1/ HIV-2.
Instructions for Use
1. Place the test cassette on a flat surface. Before unsealing the pouch, allow the test cassette to reach room temperature (4-30°C). Use it immediately once unsealed.
2. Open the pouch and add 1 drop (30-40µL) of the specimen into the sample well (S).
3. When the specimen is completely absorbed, slowly add 1 drop (45-55µL) of diluent buffer vertically into the sample well (S).
4. Avoid dropping specimen or diluent buffer in the observation window.
5. Do not allow the diluent buffer bottle to touch the sample well when dropping the diluent buffer so as to prevent cross-contamination with the specimen.
6. Observe the result between 15-30 minutes after the diluent buffer added.
Result Interpretation
1. Negative: No red lines appear within 30 minutes in the test zone (1 and 2), only a red line in the control zone (C), which indicates that no antibodies to HIV1+2 have been detected with this test. However, this does not exclude the possibility from infection with HIV.
2. Positive: One red line in the control zone (C) and one or two red visible lines of any intensity in the test zone (1 and 2). indicate the specimen contains HIV-1 and/ or HIV-2 antibodies.
3. Invalid: No red lines appear in the control zone (C), regardless of whether there is a red line in the test zone (1 and 2), indicating that the test is invalid. Discard the test cassette and perform with new cassette.
Built-In Control Newscen HIV (1+2) Antibody Rapid Test has a built-in procedural control that demonstrates assay validity. A red line appeared on the control zone (C) indicates that the test runs correctly.
CONTACT US
SITEMAP
FOLLOW
DSC MEDICAL TECH
Copyright ©️ Shanghai Dashuncome Pharmaceutical Technology Co., Ltd. All Rights Reserved.
